When developing a drug, and before releasing it into the market, there are certain milestones that cannot be bypassed when assessing a drug’s ADME properties and safety. This translates to a need for impeccable DMPK studies. For almost 15 years, PharmaLegacy’s experts have been honing their skills to provide your pipeline with the seamless DMPK studies they deserve.

Download the brochure for more information on our DMPK capabilities and to see sample data.